These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 25541279

  • 1. Ameliorative potential of omega 3 fatty acids and HMG-CoA reductase inhibitors on experimentally-induced non-alcoholic steatohepatitis.
    Kabel AM, Abd Elmaaboud MA, Albarraq AA.
    Prostaglandins Leukot Essent Fatty Acids; 2015 May; 96():1-9. PubMed ID: 25541279
    [Abstract] [Full Text] [Related]

  • 2. The Glucagon-Like Peptide-1 Analogue Liraglutide Inhibits Oxidative Stress and Inflammatory Response in the Liver of Rats with Diet-Induced Non-alcoholic Fatty Liver Disease.
    Gao H, Zeng Z, Zhang H, Zhou X, Guan L, Deng W, Xu L.
    Biol Pharm Bull; 2015 May; 38(5):694-702. PubMed ID: 25947915
    [Abstract] [Full Text] [Related]

  • 3. Resveratrol and fenofibrate ameliorate fructose-induced nonalcoholic steatohepatitis by modulation of genes expression.
    Abd El-Haleim EA, Bahgat AK, Saleh S.
    World J Gastroenterol; 2016 Mar 14; 22(10):2931-48. PubMed ID: 26973390
    [Abstract] [Full Text] [Related]

  • 4. The hepatoprotective effect of the combination use of Fructus Schisandrae with statin--A preclinical evaluation.
    Wat E, Ng CF, Wong EC, Koon CM, Lau CP, Cheung DW, Fung KP, Lau CB, Leung PC.
    J Ethnopharmacol; 2016 Feb 03; 178():104-14. PubMed ID: 26666731
    [Abstract] [Full Text] [Related]

  • 5. A high ratio of dietary n-3/n-6 polyunsaturated fatty acids improves obesity-linked inflammation and insulin resistance through suppressing activation of TLR4 in SD rats.
    Liu HQ, Qiu Y, Mu Y, Zhang XJ, Liu L, Hou XH, Zhang L, Xu XN, Ji AL, Cao R, Yang RH, Wang F.
    Nutr Res; 2013 Oct 03; 33(10):849-58. PubMed ID: 24074743
    [Abstract] [Full Text] [Related]

  • 6. Ameliorative effect of nicorandil on high fat diet induced non-alcoholic fatty liver disease in rats.
    Elshazly SM.
    Eur J Pharmacol; 2015 Feb 05; 748():123-32. PubMed ID: 25542756
    [Abstract] [Full Text] [Related]

  • 7. Effects of combined PPAR-γ and PPAR-α agonist therapy on fructose induced NASH in rats: Modulation of gene expression.
    Abd El-Haleim EA, Bahgat AK, Saleh S.
    Eur J Pharmacol; 2016 Feb 15; 773():59-70. PubMed ID: 26825546
    [Abstract] [Full Text] [Related]

  • 8. Involvement of hepatic peroxisome proliferator-activated receptor α/γ in the therapeutic effect of osthole on high-fat and high-sucrose-induced steatohepatitis in rats.
    Zhao X, Xue J, Wang XL, Zhang Y, Deng M, Xie ML.
    Int Immunopharmacol; 2014 Sep 15; 22(1):176-81. PubMed ID: 24993341
    [Abstract] [Full Text] [Related]

  • 9. PPARα/γ agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats.
    Zhang Y, Cui Y, Wang XL, Shang X, Qi ZG, Xue J, Zhao X, Deng M, Xie ML.
    Cytokine; 2015 Sep 15; 75(1):127-35. PubMed ID: 26194065
    [Abstract] [Full Text] [Related]

  • 10. Protective effect of boswellic acids versus pioglitazone in a rat model of diet-induced non-alcoholic fatty liver disease: influence on insulin resistance and energy expenditure.
    Zaitone SA, Barakat BM, Bilasy SE, Fawzy MS, Abdelaziz EZ, Farag NE.
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Jun 15; 388(6):587-600. PubMed ID: 25708949
    [Abstract] [Full Text] [Related]

  • 11. Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation.
    Andrade JM, Paraíso AF, de Oliveira MV, Martins AM, Neto JF, Guimarães AL, de Paula AM, Qureshi M, Santos SH.
    Nutrition; 2014 Jun 15; 30(7-8):915-9. PubMed ID: 24985011
    [Abstract] [Full Text] [Related]

  • 12. Fish oil alleviated high-fat diet-induced non-alcoholic fatty liver disease via regulating hepatic lipids metabolism and metaflammation: a transcriptomic study.
    Yuan F, Wang H, Tian Y, Li Q, He L, Li N, Liu Z.
    Lipids Health Dis; 2016 Feb 01; 15():20. PubMed ID: 26832365
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic association of atorvastatin and insulin in cardiac ischemia: study in a model of type 2 diabetes with hyperlipidemia.
    Matafome P, Monteiro P, Nunes E, Louro T, Amaral C, Moedas AR, Gonçalves L, Providência L, Seiça R.
    Pharmacol Res; 2008 Feb 01; 58(3-4):208-14. PubMed ID: 18692137
    [Abstract] [Full Text] [Related]

  • 14. [Effects of glucagon-like peptide-1 on liver oxidative stress, TNF-α and TGF-β1 in rats with non-alcoholic fatty liver disease].
    Gao H, Xu L, Li D, Guang L, Deng W.
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Nov 01; 33(11):1661-4. PubMed ID: 24273273
    [Abstract] [Full Text] [Related]

  • 15. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL, Perrone CE, Mattocks DA, Ables GP, Caliendo NS, Orentreich DS, Orentreich N.
    Metabolism; 2013 Nov 01; 62(11):1651-61. PubMed ID: 23928105
    [Abstract] [Full Text] [Related]

  • 16. Apple flavonols and n-3 polyunsaturated fatty acid-rich fish oil lowers blood C-reactive protein in rats with hypercholesterolemia and acute inflammation.
    Sekhon-Loodu S, Catalli A, Kulka M, Wang Y, Shahidi F, Rupasinghe HP.
    Nutr Res; 2014 Jun 01; 34(6):535-43. PubMed ID: 25026921
    [Abstract] [Full Text] [Related]

  • 17. Naringenin reduces cholesterol-induced hepatic inflammation in rats by modulating matrix metalloproteinases-2, 9 via inhibition of nuclear factor κB pathway.
    Chtourou Y, Fetoui H, Jemai R, Ben Slima A, Makni M, Gdoura R.
    Eur J Pharmacol; 2015 Jan 05; 746():96-105. PubMed ID: 25446569
    [Abstract] [Full Text] [Related]

  • 18. Acute atorvastatin is hepatoprotective against ischaemia-reperfusion injury in mice by modulating eNOS and microparticle formation.
    Ajamieh H, Farrell GC, McCuskey RS, Yu J, Chu E, Wong HJ, Lam W, Teoh NC.
    Liver Int; 2015 Sep 05; 35(9):2174-86. PubMed ID: 25786512
    [Abstract] [Full Text] [Related]

  • 19. Biochemical parameters response to weight loss in patients with non-alcoholic steatohepatitis.
    Abd El-Kader SM, Al-Shreef FM, Al-Jiffri OH.
    Afr Health Sci; 2016 Mar 05; 16(1):242-9. PubMed ID: 27358638
    [Abstract] [Full Text] [Related]

  • 20. Regulation of adipokines by polyunsaturated fatty acids in a rat model of non-alcoholic steatohepatitis.
    Ding WJ, Wang Y, Fan JG.
    Arch Iran Med; 2014 Aug 05; 17(8):563-8. PubMed ID: 25065280
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.